Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy

Clinical trial NCT01905683 · COMPLETED

Trial details

NCT number: NCT01905683
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy

Start date: 2013-08-01
Primary completion: 2017-01-01
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.